| Source: HalifaxProj(inhibit) |
| Type: |
| A member of the Bcl-2 family of proteins, which play a crucial role in regulating apoptosis, or programmed cell death. In cancer, Mcl-1 is often overexpressed, contributing to the development and progression of various types of tumors. Mcl-1 is often overexpressed in several cancers, including hematological malignancies (like leukemia and lymphoma) and solid tumors (such as breast, lung, and prostate cancers). Mcl-1 inhibits apoptosis by binding to pro-apoptotic proteins, preventing them from triggering the cell death pathway. |
| Acute Myeloid Leukemia |
| 270- | Api, | Apigenin induces apoptosis in human leukemia cells and exhibits anti-leukemic activity in vivo via inactivation of Akt and activation of JNK |
| - | in-vivo, | AML, | U937 |
| 2572- | ART/DHA, | SRF, | Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax |
| - | in-vitro, | AML, | NA |
| 5184- | PEITC, | Phenethyl isothiocyanate exhibits antileukemic activity in vitro and in vivo by inactivation of Akt and activation of JNK pathways |
| - | vitro+vivo, | AML, | U937 |
| 3378- | QC, | CK2 and PI3K are direct molecular targets of quercetin in chronic lymphocytic leukaemia |
| - | in-vitro, | AML, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:2 Cells:% prod#:% Target#:182 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid